NewLink Genetics Corp (NASDAQ:NLNK)

Thursday’s trading has closed, but NLNK is being traded in the after-hours session. After-Hours quote »
42.13
Delayed Data
As of 3:59pm ET
 +1.08 / +2.63%
Today’s Change
17.32
Today|||52-Week Range
51.28
+5.99%
Year-to-Date

Today’s Trading

Previous close41.05
Today’s open41.98
Day’s range39.26 - 43.19
Volume851,911
Average volume (3 months)440,621
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 02/26/2015

Growth & Valuation

Earnings growth (last year)-9.82%
Earnings growth (this year)-32.11%
Earnings growth (next 5 years)--
Revenue growth (last year)-35.21%
P/E ratioNM
Price/Sales508.97
Price/Book18.70

Competitors

 Today’s
change
Today’s
% change
MACKMerrimack Pharmaceut...-0.08-0.74%
EBSEmergent BioSolution...0.000.00%
PDLIPDL BioPharma Inc-0.04-0.57%
ARNAArena Pharmaceutical...+0.04+0.85%
Data as of 4:02pm ET, 02/26/2015

Financials

Last reporting dateFebruary 26, 2015
EPS forecast (this quarter)-$0.71
Annual revenue (last year)$1.1M
Annual profit (last year)-$31.2M
Net profit margin-2,852.70%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive &
Scientific Officer
Charles J. Link
President &
Chief Medical Officer
Nicholas N. Vahanian
Corporate headquarters
Ames, Iowa

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account